Skip to content

  • INVESTORS
    • PRESENTATION

MY ACCOUNT
SCHEDULE A TEST
CALL 800-522-7424

Psychemedics
  • ABOUT
  • HAIR TESTING
    • The Science Behind Hair Testing
    • Words of Warning
    • 5-Panel Drug Test
      • Amphetamines
      • Cocaine
      • Marijuana
      • Opiates
      • PCP Hair Drug Test
    • Fentanyl Hair Drug Testing
    • Adderall Testing
    • Benzodiazepines Testing
    • Synthetic Cannabinoids
    • Hair Alcohol Testing (EtG)
    • At Home Drug Testing Kit – PDT 90
    • Hair Test FAQs
  • INDUSTRIES
    • Education/School Drug Testing
    • Transportation Industry
    • Services Industries
    • Manufacturing Industry
    • Oil and Gas Industry
    • Law Enforcement
  • WHY PSYCHEMEDICS
  • RESOURCES
    • Blog Home
    • Press Releases
    • Newsletters
    • For Our Clients
    • Case Studies
    • Representative Cases
  • COLLECTORS
  • CONTACT

Corporate Newsletter – Oct 2017

January 16, 2020September 28, 2017 by Psychemedics

Download the PDF file Corporate Newsletter - Oct 2017.
Categories Corporate, Newsletters
Post navigation
Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test
Psychemedics School Newsletter – April 24 2017

Recent Posts

  • PSYCHEMEDICS CORPORATION WELCOMES DREW REYNOLDS TO ITS BOARD OF DIRECTORS AND ANNOUNCES THE RETIREMENT OF HARRY CONNICK FROM HIS DIRECTOR ROLE
  • We are the hair testing Pioneer & Leader
  • Driving Toward the Drug-Free Cab
  • PMD vs Urine
  • Psychemedics + Urine Testing?

Categories

  • Blog Posts
  • Corporate
  • Drug News
  • News
  • Newsletters
  • Press Releases
  • Schools
  • Uncategorized
  • Webinars
CORPORATE HEADQUARTERS
289 Great Road, Suite 200
Acton, MA 01720
United States
(800) 522-7424

PSYCHEMEDICS

Home

Hair Testing

Industries

Collectors

Call 800-522-7424

© Copyright 2022 – Psychemedics Corporation
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to the application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the Investor Relations section in order to receive the most current information made available by Psychemedics Corporation.

© 2022 Psychemedics • Built with GeneratePress